Social Listening in Gout: Impact of Proactive vs. Reactive Management on Self-Reported Emotional States

Gout affects over 9.2 million U.S. adults and is driven by hyperuricemia with monosodium urate crystal deposition, leading to flares, disability, comorbidities, increased costs, reduced productivity, and impaired quality of life. Emerging evidence links gout with anxiety and depression, highlighting a mental health burden. Despite genetic contributions to hyperuricemia, gout is often viewed as a lifestyle disease, fueling stigma and provider bias that can hinder optimal care and adherence. Undertreatment and clinical inertia contribute to uncontrolled disease and reactive care utilization (urgent/emergency care) during flares, which may worsen emotional distress. Proactive management aims to address root causes (e.g., urate lowering) in outpatient settings to prevent flares, whereas reactive management responds to acute symptoms. The study’s research question examines how proactive versus reactive gout management is associated with differences in community-reported sentiment and emotional states observed in social media conversations.

The paper references substantial prior work: prevalence and burden studies demonstrating impaired quality of life, disability, higher healthcare utilization and costs among individuals with gout; associations with comorbid hypertension, CKD, and cardiovascular disease; a meta-analysis documenting increased depression and anxiety in gout. It discusses evidence for genetic contributions to hyperuricemia and gout, juxtaposed with societal perceptions of gout as a lifestyle condition that fosters stigma, influences provider attitudes (bias toward patient behavior, diet, nonadherence), and affects care quality across disease severities. Literature on adherence barriers, provider nonadherence to guidelines, and persistent clinical inertia underscores undertreatment. Studies highlight that serum urate targets (<6 mg/dL) reduce flares and that ULT is effective yet underdosed. Collectively, prior research motivates evaluating how management approaches may shape patient emotions and experiences.

Design: Social media listening study comparing sentiment and emotional language in posts/comments about reactive versus proactive gout management using natural language processing (NLP) and statistical analyses. Data sources: Two platforms were analyzed: (1) a private Facebook group, The Gout Support Group of America (13,860 members), with 12,986 posts/comments from 2021–2022; (2) the public subreddit r/gout (9,416 members), with 107,231 submissions/replies from 2011–2022. In total, over 120,000 posts/comments were included. Processing and classification: A proprietary machine learning NLP engine (neural classifiers trained on annotated social media text) scored statements (sentences) for probability of discussing disease management (0–1 scale). A threshold of 0.99 was applied to select statements highly likely to reference management. Using UMLS metathesaurus term filters, statements were categorized into reactive management (e.g., urgent care, walk-in clinic) versus proactive management (e.g., primary care, primary care provider) based on sites of care and provider terms. Sentiment analysis: Continuous sentiment polarity was computed with TextBlob (−1 to +1 scale) to evaluate overall positivity/negativity by management type. Discrete sentiment/emotion used a bag-of-words approach on content words, mapped to NRC emotion categories (anger, anticipation, disgust, fear, joy, sadness, surprise, trust) via NRCLex and NLTK WordNet synonyms. Custom filters removed terms that could artifactually bias medical text (e.g., “urgent” in “urgent care”). Statistical analysis: Polarity compared using Welch’s two-sample t-test with Cohen’s d for effect size. Word-level positive/negative proportions and emotion category distributions compared using Pearson chi-square tests; subsequent pairwise comparisons used chi-square with Yates continuity correction and Bonferroni adjustment. Analyses were conducted in R. Significance threshold P < 0.05. Ethics: Exemption per 45 CFR § 46.104(d)(2) by Western IRB. Data stewardship agreements and privacy safeguards applied; deidentification performed; compliance with the Helsinki Declaration.

• Scope: Approximately 25% of statements had high probability of discussing management. Among management-related statements, ~0.5% referenced reactive management and ~0.6% referenced proactive management. Identified statements: 520 statements from 470 posts (reactive) and 654 statements from 586 posts (proactive).
• Polarity: Proactive management statements had significantly more positive sentiment than reactive statements (mean [SD] polarity 0.19 [0.21] vs. 0.03 [0.26]; Welch’s t(995.3) = 11.36, P < 0.001; Cohen’s d = −0.69 indicating a substantial difference favoring proactive positivity).
• Positive vs negative word proportions: Significant difference between management types (χ2 = 33.0, df = 1, P < 0.001). Reactive statements contained a larger proportion of negative words than proactive statements (59% vs 44%). Word counts: proactive 516 positive, 411 negative; reactive 279 positive, 401 negative.
• Emotion categories: Significant differences across emotion categories (χ2 = 95.9, df = 7, P < 0.001). Proactive statements were higher in positive emotions (trust, joy), whereas reactive statements were higher in negative emotions (anger, fear, sadness). Illustrative top words: proactive trust—“specialist”, “finally”, “advise”; reactive fear—“pain”, “bad”, “attack”; reactive sadness—“pain”, “shot”, “worse”. Table counts included (proactive vs reactive): trust 365 vs 182 (P < 0.001), joy 132 vs 76 (P < 0.05), fear 172 vs 232 (P < 0.001), sadness 138 vs 187 (P < 0.001), anger 102 vs 130 (P < 0.05), anticipation 230 vs 169, disgust 95 vs 86, surprise 111 vs 120.
• Medications: Significant differences in medication mentions between groups (χ2 = 73.3, df = 4, P < 0.001). Allopurinol appeared more often in proactive statements (65 vs 13; P < 0.001), while prednisone/steroids appeared more often in reactive statements (126 vs 51; P < 0.001). Other mentions included colchicine (49 reactive vs 38 proactive), indomethacin (27 reactive vs 7 proactive), and other NSAIDs (24 reactive vs 19 proactive).

Findings indicate that management approach correlates with community-reported emotional tone in social media discourse. Proactive management discussions were characterized by more positive sentiment and greater expressions of trust and joy, often reflecting collaborative dialogue with clinicians and mention of disease-modifying therapies (e.g., allopurinol). In contrast, reactive management discussions centered on acute pain and flares, showed higher negativity, fear, sadness, and anger, and more frequently referenced flare-directed therapies (steroids, colchicine, NSAIDs). These patterns suggest that reactive care may be driven by negative, flare-related experiences and may be associated with higher healthcare utilization and costs without addressing long-term urate burden. Proactive, treat-to-target strategies with ULT are aligned with improved clinical outcomes and may be associated with more favorable emotional states and patient-clinician trust, potentially mitigating stigma and psychological burden in gout.

Proactive treatment targeting hyperuricemia appears associated with more positive mood and trust, whereas reactive, flare-focused care corresponds to negative emotional states and may exacerbate stress, anxiety, and depression. Shifting gout care toward proactive outpatient management and ULT optimization could reduce reactive, flare-driven patterns and improve overall emotional well-being, comorbidity management, and perceived stigma. Social media listening offers a scalable means to capture real-world patient experiences, track trends, and inform interventions to improve quality of life in gout and other chronic diseases.

• Category overlap: Proactive and reactive samples may not be fully distinct; mentions of primary care could include reactive, symptom-focused encounters, potentially attenuating or exaggerating contrasts.
• Generalizability: Social media users are a self-selected population; representativeness of the general gout population and specific underrepresented groups is uncertain.
• Platform/context biases: Data drawn from Facebook and Reddit communities; platform culture and moderation may influence content.
• Text analysis constraints: Lexicon-based sentiment/emotion methods and term filtering may misclassify some medical language despite custom filters.
• Observational design: Cannot infer causality between management approach and emotional states; findings reflect associations in self-reported, unverified narratives.